Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents

Risk for Incident Atrial Fibrillation in Patients Who Receive Antihypertensive Drugs

(2013) Beat A. Schaer   ANNALS OF INTERNAL MEDICINE

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

(2013) Bertram Pitt et al.   EUROPEAN HEART JOURNAL

Sequential comparison of aldosterone synthase inhibition and mineralocorticoid blockade in patients with primary aldosteronism

(2013) Laurence Amar et al.   JOURNAL OF HYPERTENSION

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013) Giuseppe Mancia et al.   JOURNAL OF HYPERTENSION

Dominance of Furosemide for Loop Diuretic Therapy in Heart Failure

(2013) Behnood Bikdeli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Discovery of BAY 94-8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases

(2012) Lars Bärfacker et al.   ChemMedChem

Superiority of Long-Acting to Short-Acting Loop Diuretics in the Treatment of Congestive Heart Failure

(2012) Tohru Masuyama et al.   CIRCULATION JOURNAL

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

(2012) et al.   EUROPEAN HEART JOURNAL

Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice

(2012) F. Zannad et al.   EUROPEAN HEART JOURNAL

A Double-Blind, Placebo-Controlled, Crossover Trial Comparing the Effects of Amiloride and Hydrochlorothiazide on Glucose Tolerance in Patients With Essential Hypertension

(2012) Anna J. Stears et al.   HYPERTENSION

Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension

(2012) GianLuca Colussi et al.   JOURNAL OF HYPERTENSION

Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure

(2012) Karl Swedberg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Aldosterone synthase inhibition in humans

(2012) Michel Azizi et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension

(2011) David A. Calhoun et al.   CIRCULATION

A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism

(2011) Hari K Parthasarathy et al.   JOURNAL OF HYPERTENSION

NKCC1 and hypertension: a novel therapeutic target involved in the regulation of vascular tone and renal function

(2010) Sergei N Orlov et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule

(2010) Jérôme Fagart et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Combination therapy in hypertension

(2010) Alan H. Gradman et al.   Journal of the American Society of Hypertension

Aldosterone: effects on the kidney and cardiovascular system

(2010) Marie Briet et al.   Nature Reviews Nephrology

Sodium Retention in Heart Failure and Cirrhosis

(2009) Shweta Bansal et al.   Circulation-Heart Failure

Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis

(2009) S. D. Navaneethan et al.   Clinical Journal of the American Society of Nephrology

Use of Diuretics in Patients with Hypertension

(2009) Michael E. Ernst et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment

(2008) Cristiana Catena   ARCHIVES OF INTERNAL MEDICINE

Characterization of Resistant HypertensionAssociation Between Resistant Hypertension, Aldosterone, and Persistent Intravascular Volume Expansion

(2008) Krishna K. Gaddam   ARCHIVES OF INTERNAL MEDICINE

Spironolactone use and the risk of upper gastrointestinal bleeding: a population-based case-control study

(2008) Sinem E. Gulmez et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone

(2008) P. Mulder et al.   EUROPEAN HEART JOURNAL

Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism

(2008) Asterios Karagiannis et al.   EXPERT OPINION ON PHARMACOTHERAPY

A Number of Marketed Dihydropyridine Calcium Channel Blockers Have Mineralocorticoid Receptor Antagonist Activity

(2008) Jessica D. Dietz et al.   HYPERTENSION

Ethnic Differences in Renal Responses to Furosemide

(2008) Tae-Yon Chun et al.   HYPERTENSION

Drug Insight: eplerenone, a mineralocorticoid-receptor antagonist

(2007) Frances McManus et al.   Nature clinical practice. Endocrinology & metabolism